E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/29/2012 in the Prospect News PIPE Daily.

Miraculins takes in C$2.45 million through private placement of units

Company offers units at C$0.11 apiece along with two-year warrants

By Devika Patel

Knoxville, Tenn., March 29 - Miraculins Inc. announced it settled a C$2.45 million private placement of units.

The company sold 22,293,559 units of one common share and one half-share warrant at C$0.11 per unit. Each whole warrant is exercisable at C$0.16 for two years. The strike price represents a 28% premium to the March 28 closing share price of C$0.125.

Insiders participated for 1,090,909 units.

Proceeds will be used for general corporate purposes, including sales and marketing costs related to the company's PreVu test.

Based in Winnipeg, Man., Miraculins is a medical diagnostic development company focused on non-invasive tests for unmet clinical needs.

Issuer:Miraculins Inc.
Issue:Units of one common share and one half-share warrant
Amount:C$2,452,292
Units:22,293,559
Price:C$0.11
Warrants:One half-share warrant per unit
Warrant expiration:Two years
Warrant strike price:C$0.16
Settlement date:March 29
Stock symbol:TSX Venture: MOM
Stock price:C$0.125 at close March 28
Market capitalization:C$8.09 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.